In 2009, the Food and Drug Administration rejected an artificial hip manufactured by Johnson & Johnson. However, the company continued to sell the hip replacement in Europe and marketed a related model stateside. More than 90,000 patients worldwide used these faulty devices, and resulted in painful corrective surgery for many. In the wake of an August 2010 recall and thousands of lawsuits, Johnson & Johnson has lost at least $3 billion. Barry Meier is reporter for our partner The New York Times.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. Will you support The World with a gift today? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!